Conference Description:

Topics covered will include genetics and genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies, the state of the molecular autopsy, and the state of gene therapy for CV diseases.

Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gauge outcome. Two “early bird” special workshops will be conducted to analyze your genetic test reports and to comment on the significance of the genetic test results and the implications for your patients.

Time: 7:00 AM - 12:00 PM

Prices:
MD, PhD, DO: USD 750.00,
Medical Students, Fellows in Training, PA, NP, RN, GC, PharmD: USD 650.00